Beth Israel Deaconess Medical Center-ko ikertzaileekin lankidetzan egindako argitalpenak (10)

2023

  1. Bleeding and Ischemic Risks of Ticagrelor Monotherapy After Coronary Interventions

    Journal of the American College of Cardiology, Vol. 82, Núm. 8, pp. 687-700

2022

  1. Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI: A Prespecified TWILIGHT Substudy

    JACC: Cardiovascular Interventions, Vol. 15, Núm. 3, pp. 282-293

  2. Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 18, Núm. 11, pp. e897-e909

2021

  1. Impact of Age on the Safety and Efficacy of Ticagrelor Monotherapy in Patients Undergoing PCI

    JACC: Cardiovascular Interventions, Vol. 14, Núm. 13, pp. 1434-1446

  2. Sex Differences among Patients with High Risk Receiving Ticagrelor with or without Aspirin after Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical Trial

    JAMA Cardiology, Vol. 6, Núm. 9, pp. 1032-1041

  3. Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis

    JACC: Cardiovascular Interventions, Vol. 14, Núm. 4, pp. 444-456

  4. Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD

    European Heart Journal, Vol. 42, Núm. 45, pp. 4683-4693

2020

  1. Ticagrelor alone vs.Ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS

    European Heart Journal, Vol. 41, Núm. 37, pp. 3533-3545

2019

  1. Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention: A Global Expert Consensus Document

    Circulation, Vol. 140, Núm. 5, pp. 420-433

  2. Ticagrelor with or without aspirin in high-risk patients after PCI

    New England Journal of Medicine, Vol. 381, Núm. 21, pp. 2032-2042